Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate a new diagnostic imaging test, positron emission
tomography (PET), with a different radioactive form of iodine called iodine-124. This form is
able to accurately measure the amount of radioactive iodine uptake in the cancer. If the new
test determines sufficient radioiodine uptake in the cancer, treatment will continue as
usual. However, if the new test shows only low radioiodine uptake, a decision may be made
that the benefit from radioiodine therapy is insufficient and that another form of therapy is
preferred.